Nanoform Finland Plc

NANOFS · Nasdaq Stockholm · Healthcare

9.40SEK −2.1%last day

Price as of 2 October 2026

The price over the past year, with dividends: −35.6%

Performance

1 month

−10.3%

1 year

−35.6%

3 years, per year

−24.1%

5 years, per year

−34.8%

Largest fall, 3 years

−87.2%

Below the peak now

−89.1%

Volatility, 1 year

84.1%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.9

Dividend yield

0.0%

Return on equity

−37.9%

Net margin

–

Market value

80 m USD

Quality, value and trend

Where Nanoform Finland stands against every Nordic stock today. 100 is best.

Quality62

Profitability and a sound balance sheet over time. Better than 62% of Nordic stocks.

Value12

The price measured against earnings, assets and cash flow. Better than 12% of Nordic stocks.

Trend70

The price development over the past year. Better than 70% of Nordic stocks.

Combined43

Quality, value and trend together. Better than 43% of Nordic stocks.

About Nanoform Finland

Nanoform Finland Plc is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 110 employees.

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predicts the performance of your molecule in Nanoform's technology. The company was founded in 2008 and is headquartered in Helsinki, Finland.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis